Hypernil 10 mg Research Overview
Hypernil 10 mg Lupin is a pharmaceutical-grade amlodipine besylate calcium channel blocker manufactured by Lupin Pharmaceuticals for cardiovascular research applications. This dihydropyridine-class calcium channel antagonist provides researchers with standardised tablet formulations to investigate calcium-dependent cellular mechanisms and vascular pharmacology. Each tablet contains precisely dosed amlodipine besylate equivalent to 10 mg amlodipine base, enabling controlled dose-response studies and mechanistic research into calcium channel modulation pathways.
Calcium Channel Research Applications
Research scientists studying cardiovascular pharmacology utilise amlodipine compounds to examine calcium channel blocking mechanisms across various experimental models. The compound demonstrates selective affinity for L-type calcium channels, making it valuable for investigating vascular smooth muscle calcium influx and related cellular signalling pathways. Researchers at Stroid UK Shop can access this pharmaceutical-grade formulation for studies examining calcium-dependent vasoconstriction mechanisms and endothelial function. Laboratory investigations often compare amlodipine’s calcium channel selectivity against other compounds available in our amlodipine research collection, while complementary studies may examine metabolic effects using compounds from our SARM research range or cellular signalling modulators from our peptide research portfolio. This pharmaceutical preparation enables consistent experimental conditions across multiple research protocols examining calcium channel physiology.
Hypernil Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Amlodipine Besylate (equivalent to 10 mg amlodipine) |
| Manufacturer | Lupin Pharmaceuticals |
| Formulation | Oral Tablet |
| CAS Number | 111470-99-6 (amlodipine besylate) |
| Molecular Formula | C₂₆H₃₁ClN₂O₈S |
| Storage Conditions | Room temperature, dry environment |
Laboratory Compliance Information
Hypernil 10 mg tablets are supplied strictly for in-vitro research purposes only and are not intended for human consumption. This pharmaceutical-grade amlodipine formulation must be handled by qualified laboratory personnel following appropriate safety protocols for calcium channel blocker compounds. Researchers should maintain proper storage conditions and disposal procedures in accordance with institutional laboratory safety guidelines. All experimental work should be conducted within approved laboratory facilities with appropriate ventilation and safety equipment when handling pharmaceutical compounds.
